Thrombodyne

Thrombodyne was a medical diagnostic company that specialized in point-of-care platelet function testing. The company developed the Plateletworks system, a rapid bedside test designed to measure platelet aggregation and monitor the efficacy of antiplatelet medications such as aspirin and P2Y12 inhibitors. This technology allowed clinicians to make immediate decisions during surgical or interventional procedures by providing results in under five minutes. Thrombodyne's assets and technology were acquired by Helena Laboratories, which integrated the Plateletworks platform into its broader portfolio of coagulation and hematology products. The system remains a recognized tool in clinical settings for assessing bleeding risk and therapeutic response.